Drug firm Glenmark Pharma on Tuesday announced the launch of Tiotropium Bromide Dry Powder Inhaler, used in the treatment of chronic obstru...

A total of 292,263 shares changed hands on the counter till 11:00AM (IST).

Drug major Cipla on Monday said it has submitted an application with the US health regulator for a generic version of GSK's Advair Diskus, ...

Here is a lowdown of the movers and shakers of Friday’s session on Dalal Street.

The generic would be used for treatment of asthma and chronic obstructive pulmonary disease.

Strides Pharma said it has ceased distribution of its ranitidine tablets in the US market.

The drug, Fluticasone/Salmeterol dry powder inhaler (DPI), is a generic version of GlaxoSmithKline’s Seretide Accuhaler.

This is the second inhalation product in-licensed by Glenmark for the European market after Fluticasone/Salmeterol dry powder inhaler, the ...

The product was developed by Celon Pharma and Glenmark has marketing and distribution rights for the product across 15 European countries.

As per the agreement, Glenmark has obtained semi-exclusive marketing and distribution rights of the product across 15 European countries

Asthma patients may breathe easier as GSK has halved the prices of its Seretide inhaler in India to match that of Cipla’s competing brand S...

Lupin has set up a dedicated centre of excellence for inhalation research in Florida after having hired top notch inhalation scientists las...

According to analysts, rollout of inhalers in Europe and supplies of esomeprazole (Nexium) to Teva will be key triggers for the stock in co...

Pharmaceutical firm Cipla today announced commercial collaboration with UK-based S&D Pharma in the Czech Republic and Slovakia.

The rally post polls was led by cyclicals on anticipation of reforms. However, investors continued to churn portfolios post the earnings se...

Analysts at Emkay Global Financial Services are of the view that the launch will have a strong positive impact on the company’s margins.

Ranbaxy Laboratories Ltd on Tuesday announced the launch of its branded product, Avessa inhalation capsules in India for the treatment of A...